How to calculate the dose of chemotherapy

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Body surface area-dosing does not account for the complex processes of cytotoxic drug elimination. This leads to an unpredictable variation in effect. Overdosing is easily recognised but it is possible that unrecognised underdosing is more common and may occur in 30% or more of patients receiving standard regimen. Those patients who are inadvertently underdosed are at risk of a significantly reduced anticancer effect. Using published data, it can be calculated that there is an almost 20% relative reduction in survival for women receiving adjuvant chemotherapy for breast cancer as a result of unrecognised underdosing. Similarly, the cure rate of cisplatin-based chemotherapy for advanced testicular cancer may be reduced by as much as 10%. The inaccuracy of body surface area-dosing is more than an inconvenience and it is important that methods for more accurate dose calculation are determined, based on the known drug elimination processes for cytotoxic chemotherapy. Twelve rules for dose calculation of chemotherapy are given that can be used as a guideline until better dose-calculation methods become available. Consideration should be given to using fixed dose guidelines independent of body surface area and based on drug elimination capability, both as a starting dose and for dose adjustment, which may have accuracy, safety and financial advantages.

LanguageEnglish
Pages1297-1302
Number of pages6
JournalBritish Journal of Cancer
Volume86
Issue number8
DOIs
Publication statusPublished - 22 Apr 2002
Externally publishedYes

Fingerprint

Body Surface Area
Drug Therapy
Pharmaceutical Preparations
Guidelines
Testicular Neoplasms
Adjuvant Chemotherapy
Cisplatin
Breast Neoplasms
Safety
Survival

Keywords

  • Body surface area
  • Dose calculation
  • Under-dose

Cite this

@article{b97f2dbd763a47beb4d73f62fc41cc3c,
title = "How to calculate the dose of chemotherapy",
abstract = "Body surface area-dosing does not account for the complex processes of cytotoxic drug elimination. This leads to an unpredictable variation in effect. Overdosing is easily recognised but it is possible that unrecognised underdosing is more common and may occur in 30{\%} or more of patients receiving standard regimen. Those patients who are inadvertently underdosed are at risk of a significantly reduced anticancer effect. Using published data, it can be calculated that there is an almost 20{\%} relative reduction in survival for women receiving adjuvant chemotherapy for breast cancer as a result of unrecognised underdosing. Similarly, the cure rate of cisplatin-based chemotherapy for advanced testicular cancer may be reduced by as much as 10{\%}. The inaccuracy of body surface area-dosing is more than an inconvenience and it is important that methods for more accurate dose calculation are determined, based on the known drug elimination processes for cytotoxic chemotherapy. Twelve rules for dose calculation of chemotherapy are given that can be used as a guideline until better dose-calculation methods become available. Consideration should be given to using fixed dose guidelines independent of body surface area and based on drug elimination capability, both as a starting dose and for dose adjustment, which may have accuracy, safety and financial advantages.",
keywords = "Body surface area, Dose calculation, Under-dose",
author = "H. Gurney",
year = "2002",
month = "4",
day = "22",
doi = "10.1038/sj.bjc.6600139",
language = "English",
volume = "86",
pages = "1297--1302",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Springer, Springer Nature",
number = "8",

}

How to calculate the dose of chemotherapy. / Gurney, H.

In: British Journal of Cancer, Vol. 86, No. 8, 22.04.2002, p. 1297-1302.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - How to calculate the dose of chemotherapy

AU - Gurney, H.

PY - 2002/4/22

Y1 - 2002/4/22

N2 - Body surface area-dosing does not account for the complex processes of cytotoxic drug elimination. This leads to an unpredictable variation in effect. Overdosing is easily recognised but it is possible that unrecognised underdosing is more common and may occur in 30% or more of patients receiving standard regimen. Those patients who are inadvertently underdosed are at risk of a significantly reduced anticancer effect. Using published data, it can be calculated that there is an almost 20% relative reduction in survival for women receiving adjuvant chemotherapy for breast cancer as a result of unrecognised underdosing. Similarly, the cure rate of cisplatin-based chemotherapy for advanced testicular cancer may be reduced by as much as 10%. The inaccuracy of body surface area-dosing is more than an inconvenience and it is important that methods for more accurate dose calculation are determined, based on the known drug elimination processes for cytotoxic chemotherapy. Twelve rules for dose calculation of chemotherapy are given that can be used as a guideline until better dose-calculation methods become available. Consideration should be given to using fixed dose guidelines independent of body surface area and based on drug elimination capability, both as a starting dose and for dose adjustment, which may have accuracy, safety and financial advantages.

AB - Body surface area-dosing does not account for the complex processes of cytotoxic drug elimination. This leads to an unpredictable variation in effect. Overdosing is easily recognised but it is possible that unrecognised underdosing is more common and may occur in 30% or more of patients receiving standard regimen. Those patients who are inadvertently underdosed are at risk of a significantly reduced anticancer effect. Using published data, it can be calculated that there is an almost 20% relative reduction in survival for women receiving adjuvant chemotherapy for breast cancer as a result of unrecognised underdosing. Similarly, the cure rate of cisplatin-based chemotherapy for advanced testicular cancer may be reduced by as much as 10%. The inaccuracy of body surface area-dosing is more than an inconvenience and it is important that methods for more accurate dose calculation are determined, based on the known drug elimination processes for cytotoxic chemotherapy. Twelve rules for dose calculation of chemotherapy are given that can be used as a guideline until better dose-calculation methods become available. Consideration should be given to using fixed dose guidelines independent of body surface area and based on drug elimination capability, both as a starting dose and for dose adjustment, which may have accuracy, safety and financial advantages.

KW - Body surface area

KW - Dose calculation

KW - Under-dose

UR - http://www.scopus.com/inward/record.url?scp=0037156937&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6600139

DO - 10.1038/sj.bjc.6600139

M3 - Article

VL - 86

SP - 1297

EP - 1302

JO - British Journal of Cancer

T2 - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 8

ER -